10% SSS Can’t Last
Vitamin Shoppe (VSI) is doing well becasue same store is strong. Still, I feel this stock is fully valued and people should invest in GNC (GNC) instead.
Vitamin Shoppe (VSI) is doing well becasue same store is strong. Still, I feel this stock is fully valued and people should invest in GNC (GNC) instead.
Some top stocks for 2012 are acting weak because investors are selling before taxes rise in 2013. But selling a stock down 20% isn’t worth saving 5% of gains.
Express Scripts (ESRX) is a conservative stock with little downside risk that is tremendously undervalued right now. ESRX is one of my top picks for 2013.
Here’s my step-by-step plan on what to do now that Obama’s won. This is Part Two of a two part series. This month: What to Buy
Everybody keeps dissing Priceline.com (PCLN). The stock has a P/E in the teens even as it’s one of the best stocks this decade. Time for a move up.
LinkedIn (LNKD) was $99 this quarter. It’s worth $77 next year and $128 the year after. Where do you buy? Hold out for the low-$90.
Mastercard (MA) is losing its green. Quarterly growth has dipped below 20% and estimates show more of that ahead.
Take a break Catamaran (CTRX), you deserve a break after the 75% rise your stock’s had this year. Looking at estimates, it seems like another rise is on the horizon.
Portfolio Recovery Associates (PRAA) had another successful quarter, but the stock didn’t go up as it should have. I think this $100 stock is worth $150.
Altisource Portfolio Solutions (ASPS) has been one of the hottest stocks of 12. ASPS just missed, that settled the stock down, but I still see ASPS going higher.
Amazon.com (AMZN) continues to build new order fulfillment centers across the globe. That’s hurting profits now, but will help profits in the (far) future.
Shares of Celgene (CELG) have been trending higher as of late. Backed by an all-green one-year chart, the trend is your friend.